CDC Company: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CDC Company
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Debts after one year -€16,333
down €16,333 (-17.2%), from €95,168 to €78,834
- Other debts +€12,382
up €12,382 (+3.7%), from €335,015 to €347,398
- Financial income -€31,500
down €31,500 (-63.0%), from €50,000 to €18,500
- Financial charges +€5,237
up €5,237 (+68.9%), from €7,605 to €12,842
- Depreciation -€1,602
no longer reported in 2025 (was €1,602)
- Other operating charges +€836
up €836 (+8,358,200%), from €0 to €836
- Gross operating margin +€381
up €381 (+21.2%), from -€1,800 to -€1,419
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €491,580 | €491,355 | -€225 | 0.0% |
| Fixed assets | 21/28 | €480,000 | €480,000 | = | 0.0% |
| Financial fixed assets | 28 | €480,000 | €480,000 | = | 0.0% |
| Current assets | 29/58 | €11,580 | €11,355 | -€225 | -1.9% |
| Amounts receivable within one year | 40/41 | €8,595 | €8,595 | = | 0.0% |
| Other amounts receivable | 41 | €8,595 | €8,595 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €2,986 | €2,760 | -€225 | -7.6% |
| Total equity and liabilities | 10/49 | €491,580 | €491,355 | -€225 | 0.0% |
| Equity | 10/15 | €42,894 | €46,297 | +€3,403 | +7.9% |
| Contributions | 10/11 | €3,900 | €3,900 | = | 0.0% |
| Profit (loss) carried forward | 14 | €38,994 | €42,397 | +€3,403 | +8.7% |
| Amounts payable | 17/49 | €448,686 | €445,057 | -€3,629 | -0.8% |
| Amounts payable after more than one year | 17 | €95,168 | €78,834 | -€16,333 | -17.2% |
| Financial debts | 170/4 | €95,168 | €78,834 | -€16,333 | -17.2% |
| Amounts payable within one year | 42/48 | €353,087 | €365,855 | +€12,768 | +3.6% |
| Current portion of amounts payable after more than one year | 42 | €18,071 | €18,457 | +€386 | +2.1% |
| Other amounts payable | 47/48 | €335,015 | €347,398 | +€12,382 | +3.7% |
| Accrued charges and deferred income | 492/3 | €432 | €368 | -€64 | -14.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,602 | - | -€1,602 | |
| Other operating charges | 640/8 | €0 | €836 | +€836 | +8,358,200% |
| Gross operating margin | 9900 | -€1,800 | -€1,419 | +€381 | +21.2% |
| Operating profit (loss) | 9901 | -€3,401 | -€2,255 | +€1,147 | +33.7% |
| Financial income | 75/76B | €50,000 | €18,500 | -€31,500 | -63.0% |
| Recurring financial income | 75 | €50,000 | €18,500 | -€31,500 | -63.0% |
| Financial charges | 65/66B | €7,605 | €12,842 | +€5,237 | +68.9% |
| Recurring financial charges | 65 | €7,605 | €12,842 | +€5,237 | +68.9% |
| Profit (loss) for the period before taxes | 9903 | €38,994 | €3,403 | -€35,590 | -91.3% |
| Profit (loss) for the period | 9904 | €38,994 | €3,403 | -€35,590 | -91.3% |
| Profit (loss) for the period to be appropriated | 9905 | €38,994 | €3,403 | -€35,590 | -91.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.